Reducing the crystallinity of PCL chains by copolymerization with substituted /-lactones and its impact on the phase separation of PCL-based block copolymers

Various substituted delta/epsilon-lactones have been copolymerized with epsilon-caprolactone (epsilon-CL) with the aim to inhibit the crystallization of polycaprolactone (PCL). Among the studied co-monomers, the best results were obtained with the 4-phenyl-epsilon-caprolactone (4-Ph-epsilon-CL) co-monomer. Its copolymerization with epsilon-CL using methane sulfonic acid (MSA) as ring-opening polymerization (ROP) organo-catalyst afforded highly random P(epsilon-CL-co-4-Ph-epsilon-CL) copolymers (the corresponding reactivity ratios have been determined as 0.67 for epsilon-CL and 0.60 for 4-Ph-epsilon-CL). DSC analyses revealed that amorphous samples were obtained when 20% or more of 4-Ph-epsilon-CL was incorporated into the PCL chains. The 4-Ph substituent is most efficient at preventing PCL crystallization by impeding chain folding and alignment, while it only slightly impacts the polymerization rate. Using telechelic dihydroxyl-terminated (hydrogenated) polybutadiene macroinitiators, MSA-catalyzed ROP chain extension led to well-defined triblock copolymers, as supported by NMR and SEC analyses. A combination of SAXS, WAXS and DMA studies revealed the intricate segregation behavior of these triblock copolymers with respect to the semi-crystalline vs. amorphous character of the PCL-type blocks.